S100B

S100B 분자 정보

영어 이름Protein Nef시판 약물 수0
임상 약물 수1표적 별명nef,Negative factor,3'ORF,Protein Nef,F-protein
최고 연구 개발 단계Phase 1 Clinical
영어 이름Protein Nef
표적 별명nef,Negative factor,3'ORF,Protein Nef,F-protein
시판 약물 수0
임상 약물 수1
최고 연구 개발 단계Phase 1 Clinical

S100B 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • Human (1)

  • 태그

    His Tag (1)

  • 마커

    Unconjugated (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
S1B-H5143
Human
E. coli
Human S100B Protein, His Tag
총 수량1
  • 1

S100B분자 배경

S-100 protein beta chain (S100B),a member of the S-100 family, is also known as S-100 protein subunit beta and S100 calcium-binding protein B, which contains two EF-hand domains. S100B can weakly bind calcium but bind zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Also, S100B can bind to and initiate the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction,S100B may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Fuethermore,S100B could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization. S100B may mediate calcium-dependent regulation on many physiological processes by interacting with other proteins, such as TPR-containing proteins, and modulating their activity.

S100B분자 별명

S100B,NEF,S100,S100beta

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
HIV clade B mRNA dendritic cell therapy (Immunomic Therapeutics/Universite Libre de Bruxelles)Phase 1 ClinicalImmunomic Therapeutics IncHIV Infections
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호